Drugs that activate brain stem cells may reverse multiple sclerosis in mice

Two drugs already on the market — an antifungal and a steroid — may potentially take on new roles as treatments for multiple sclerosis. According to a study in Nature, researchers discovered that these drugs may activate stem cells in the brain to stimulate myelin producing cells and repair white matter, which is damaged in multiple sclerosis. The study was partially funded by the NIH’s National Institute of Neurological Disorders and Stroke (NINDS).
Source: NINDS Press Releases and News: National Institute of Neurological Disorders and Stroke - Category: Neurology Source Type: news